Fund moves
1.75MShares reported
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
A · NYSE · Life Sciences Tools & Services
Agilent Technologies (A) · oqro.io/stocks/A · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Baskets of the companies that insiders, members of Congress or funds recently reported buying, each held under a written rule.
$170.38−4.96 (−2.83%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
No open-market purchase by an insider of Agilent Technologies was filed in the last 90 days. The latest on record was on Sep 28, 2023.
Since 2006, Agilent Technologies insiders reported 16 open-market purchases and 524 sales on Forms 4 and 5, with purchases in 3 different years, most recently 2023.
In the last 90 days, 1 insider of Agilent Technologies (A) reported 1 open-market sale worth $96K in total on SEC Form 4. The largest seller by value was Mikael Dolsten, with $96K. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Yes. Members of Congress disclosed 2 trades in Agilent Technologies (A) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent is from Rep. Julie Johnson (TX32).
Agilent Technologies's next results are expected on Nov 23, 2026, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+17.5% (+$25.32) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $145.06 on Nov 20, 2025 to $170.38 on Nov 20, 2026 (+17.5%). Disclosed in this range: 1 insider trade, 3 pre-arranged insider sales, 0 Congress trades, and 61 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Life Sciences Tools & Services company based in Santa Clara, California.
Last 12 months
+21.4%
Market value
$49.4B
S&P 500 +8.0% over the same dates. Prices adjusted for splits and dividends.
Short interest: 4.89M shares sold short (1.7% of shares outstanding), −2.6% vs the previous count, 2.2 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
Revenue, fiscal 2025
$6.95B
+6.7% vs the year before
Net income, fiscal 2025
$1.3B
As reported in the annual filing
Shares outstanding
282M
As of Aug 26, 2026
In fiscal 2025 the company spent $425M buying back its own shares and $282M on dividends. Cash actually paid, from its cash-flow statement.
New federal contracts from the last 12 months add up to 0.25% of that revenue. Contract money is usually earned over several years, so this is a size comparison, not a share of sales.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Federal contracts
Agilent lab equipment EO13498
The Department of Health and Human Services has committed $2.6M to Agilent Technologies so far. It runs until Feb 28, 2027.
Federal contracts
This acquisition is for the procurement of up to 174 bulk resolution technology (BRT) systems, including delivery, installation…
The Department of Homeland Security has committed $10.7M to Agilent Technologies so far. It runs until Mar 29, 2029.
Mikael Dolsten (Director) sold ~$96K of Agilent Technologies
Automatic salePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Revenue
$1.88B
+8.1% vs the same quarter a year earlier
Free cash flow, last 12 months
$1.27B
This quarter $439M, a year earlier $259M
Net debt
$1.89B
Debt $3.65B, cash $1.76B, at Jul 31, 2026
Net income, last 12 months
$1.44B
Operating profit covers interest 15.5x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 26, 2026.
Revenue and earnings history, 19 fiscal yearsRevenue breakdown: where the money goesCompared with its peersEarnings dates and the stock's moves
Against the S&P 500 over the year
Since Nov 19, 2025, A is up 18.0% and the index fund is up 4.1%: 14 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much A moves
Beta 0.9 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
Insiders of Agilent Technologies reported 16 open-market purchases and 524 sales since 2006; purchases in 3 different years, most recently 2023.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $313K2×2 trades |
| 2025 | — | $5.13M12×12 trades |
| 2024 | — | $14.5M12×12 trades |
| 2023 | $2882×2 trades | $13.3M7×7 trades |
| 2022 | — | $39.9M23×23 trades |
| 2021 | — | $53M30×30 trades |
| 2020 | — | $30.7M28×28 trades |
| 2019 | — | $18.8M25×25 trades |
| 2018 | — | $12.7M16×16 trades |
| 2017 | — | $36.2M43×43 trades |
| 2016 | — | $14.3M22×22 trades |
| 2015 | — | $13.5M15×15 trades |
| 2014 | — | $61.9M15×15 trades |
| 2013 | — | $34.9M24×24 trades |
| 2012 | $65K2×2 trades | $18.3M18×18 trades |
| 2011 | — | $49.6M38×38 trades |
| 2010 | — | $42.2M34×34 trades |
| 2009 | — | $31.1M26×26 trades |
| 2008 | — | $4.86M18×18 trades |
| 2007 | — | $23.2M97×97 trades |
| 2006 | $616K12×12 trades | $7.39M19×19 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Top officer leaving
“(the "Company"), notified the Chairman of the Board of his decision to retire from the Board, effective as of December 1, 2026 (the "Effective Date").”
8-K on sec.govTop officer leaving
“As previously disclosed, on March 5, 2026, Rodney Gonsalves, informed the Company that he would retire from his position as the Company’s Vice President, Corporate Controller and Principal Accounting Officer, the exact date to be determined at a later time.”
8-K on sec.govTop officer leaving
“("Agilent") that he would retire from his position as Agilent’s Vice President, Corporate Controller and Principal Accounting Officer in January 2027, the exact date to be determined at a later time.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Vanguard Capital Management
13G · passive · Crossed 5% · 21.2M shares · filed Apr 29, 2026
Vanguard Portfolio Management
13G · passive · Crossed 5% · 14.4M shares · filed Apr 28, 2026
Recent moves
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Last results
Aug 26, 2026
More than 30 days ago
Next results, expected
Nov 23, 2026
after the market closes; the date can move until the company confirms it
Purchases after results
Not enough history
From Agilent Technologies's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Agilent Technologies's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Congress
Funds and stakes
Contracts, lobbying and filings
Company reports, price and press
Who holds it
Attention
Things to keep in mind
Records
Short sale volume: 53.3% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 46.2%. FINRA daily files, to Nov 20, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
Off-exchange trading: 46.8% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (32.1% on ATS, 14.7% with other brokers), close to its 26-week average of 45.4%. Weeks of Oct 5 to Oct 30, 2026.
Largest ATS: INTELLIGENT CROSS LLC (13.4%), SIGMA X2 (10.6%), UBS ATS (8.2%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
People read Agilent Technologies's Wikipedia article about 170 times a day over the last week, close to the 180 on a usual day of the three months before.
May 16, 2026Busiest day: 390 views on Jun 2, 2026Nov 21, 2026
Views of the article Agilent Technologies, by people (Wikimedia leaves out known bots). More readers means more attention, from news, results or anything else; it does not say anyone bought or sold. Source: Wikimedia pageviews.
Latest annual report filed Dec 22, 2025, compared with the one filed Dec 20, 2024. Read the filing
We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are probable and reasonably possible of having a material impact to our business, consolidated financial condition, results of operations or cash flows.
Source: SEC EDGAR, Form 10-K filed Dec 22, 2025. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
4 certified in FY2026 Q3, vs 15 a year earlier. 4 positions in total, median offered wage $177K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
The three months May 1, 2026 to Jul 31, 2026, compared with the same quarter a year earlier, from the quarterly report filed Sep 1, 2026. Quarterly reports are not audited. Read the filing
+5.6% on the same quarter a year earlier ($744M). Operating income $270M, a 34% margin
+11% on the same quarter a year earlier ($670M). Operating income $176M, a 24% margin
+6.8% on the same quarter a year earlier ($324M). Operating income $86M, a 25% margin
+8.4% on the same quarter a year earlier ($1.23B)
+7.3% on the same quarter a year earlier ($508M)
The company also reports Non-Instrumentation and Other ($1.24B), Instrumentation ($643M), which group lines above and are not added again.
+11% on the same quarter a year earlier ($683M)
+8.9% on the same quarter a year earlier ($563M)
+2.4% on the same quarter a year earlier ($492M)
Fiscal year Nov 1, 2024 to Oct 31, 2025, from the annual report filed Dec 22, 2025. Read the filing
+5.9% on the year before ($2.75B). Operating income $946M, a 33% margin
+11% on the year before ($2.47B). Operating income $536M, a 20% margin
+1.3% on the year before ($1.3B). Operating income $301M, a 23% margin
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 18,000 words.
Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.
And 15 more headings in the filing.
Source: SEC EDGAR, Form 10-K filed Dec 22, 2025 and Form 10-Q filed Sep 1, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
+5.8% on the year before ($4.67B)
+9.0% on the year before ($1.84B)
The company also reports Non-Instrumentation and Other ($4.52B), Instrumentation ($2.43B), which group lines above and are not added again.
+9.1% on the year before ($2.57B)
+2.4% on the year before ($2.17B)
+8.6% on the year before ($1.77B)
The company also reports Rest Of World ($3.38B), United States ($2.34B), CHINA Including Hong Kong ($1.22B), which group lines above and are not added again.